Literature DB >> 1254703

Pseudomonas cepacia strains isolated from water reservoirs of unheated nebulizers.

S M Gelbart, G F Reinhardt, H B Greenlee.   

Abstract

Pseudomonas cepacia strains were isolated from the water reservoirs of unheated nebulizers in a hospital setting. The isolates were characterized by morphology, biochemical tests, and antibiotic susceptibility patterns. An interesting feature of these organisms was their capacity for sustained multiplication in either doubly deionized or doubly distilled water as well as 5% dextrose or 0.9% saline. They could not multiply in doubly deionized and then doubly distilled water or in any of several parenteral nutrition solutions studied. Isolation of Pseudomonas cepacia from the water reservoirs of unheated nebulizers suggests that this equipment may serve as a source of respiratory tract exposure to the organism.

Entities:  

Mesh:

Year:  1976        PMID: 1254703      PMCID: PMC274227          DOI: 10.1128/jcm.3.1.62-66.1976

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Pseudomonas cepacia (multivorans) septicaemia in an intensive-care unit.

Authors:  I Phillips; S Eykyn; M A Curtis; J J Snell
Journal:  Lancet       Date:  1971-02-20       Impact factor: 79.321

2.  Hospital infection by Pseudomonas cepacia.

Authors:  D C Speller; M E Stephens; A C Viant
Journal:  Lancet       Date:  1971-04-17       Impact factor: 79.321

3.  Wound infection with Pseudomonas multivorans. A water-borne contaminant of disinfectant solutions.

Authors:  D C Bassett; K J Stokes; W R Thomas
Journal:  Lancet       Date:  1970-06-06       Impact factor: 79.321

4.  Successful treatment of Pseudomonas cepacia endocarditis with trimethoprim-sulfamethoxazole.

Authors:  J Hamilton; W Burch; G Grimmett; K Orme; D Brewer; R Frost; C Fulkerson
Journal:  Antimicrob Agents Chemother       Date:  1973-11       Impact factor: 5.191

5.  Infrequently encountered Pseudomonas species causing infection in humans.

Authors:  G L Gilardi
Journal:  Ann Intern Med       Date:  1972-08       Impact factor: 25.391

6.  Multiplication of nosocomial pathogens in intravenous feeding solutions.

Authors:  S M Gelbart; G F Reinhardt; H B Greenlee
Journal:  Appl Microbiol       Date:  1973-12

7.  Postoperative urinary-tract infections caused by contaminated irrigating fluid.

Authors:  R G Mitchell; A C Hayward
Journal:  Lancet       Date:  1966-04-09       Impact factor: 79.321

8.  Association of Pseudomonas cepacia with chronic granulomatous disease.

Authors:  E J Bottone; S D Douglas; A R Rausen; G T Keusch
Journal:  J Clin Microbiol       Date:  1975-05       Impact factor: 5.948

9.  In vitro antibiotic susceptibility of pseudomonads other than Pseudomonas aeruginosa recovered from cancer patients.

Authors:  M R Moody; V M Young; D M Kenton
Journal:  Antimicrob Agents Chemother       Date:  1972-11       Impact factor: 5.191

10.  Morphological, biochemical, and growth characteristics of pseudomonas cepacia from distilled water.

Authors:  L A Carson; M S Favero; W W Bond; N J Petersen
Journal:  Appl Microbiol       Date:  1973-03
View more
  8 in total

1.  Resistance of spheroplasts and whole cells of Pseudomonas cepacia to polymyxin B.

Authors:  J M Manniello; H Heymann; F W Adair
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

2.  Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis.

Authors:  G R Hutchinson; S Parker; J A Pryor; F Duncan-Skingle; P N Hoffman; M E Hodson; M E Kaufmann; T L Pitt
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

Review 3.  The epidemiology of nosocomial epidemic Pseudomonas cepacia infections.

Authors:  W J Martone; O C Tablan; W R Jarvis
Journal:  Eur J Epidemiol       Date:  1987-09       Impact factor: 8.082

4.  Purification and properties of a new beta-lactamase from Pseudomonas cepacia.

Authors:  K Hirai; S Iyobe; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

Review 5.  The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis.

Authors:  O C Tablan; W J Martone; W R Jarvis
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

6.  Fourteen-year survival of Pseudomonas cepacia in a salts solution preserved with benzalkonium chloride.

Authors:  S G Geftic; H Heymann; F W Adair
Journal:  Appl Environ Microbiol       Date:  1979-03       Impact factor: 4.792

7.  Virulence of different Pseudomonas species in a burned mouse model: tissue colonization by Pseudomonas cepacia.

Authors:  G B Stover; D R Drake; T C Montie
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

8.  Selective medium for Pseudomonas cepacia containing 9-chloro-9-(4-diethylaminophenyl)-10-phenylacridan and polymyxin B sulfate.

Authors:  B J Wu; S T Thompson
Journal:  Appl Environ Microbiol       Date:  1984-10       Impact factor: 4.792

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.